The panorama of familial hypercholesterolemia in Latin America: a systematic review

Homozygous familial hypercholesterolemia: phenotype rules!

(2016) Raul D. Santos   ATHEROSCLEROSIS

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   ATHEROSCLEROSIS

Knowing the Prevalence of Familial Hypercholesterolemia Matters: Table.

(2016) Anne C. Goldberg et al.   CIRCULATION

Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)CLINICAL PERSPECTIVE

(2016) Sarah D. de Ferranti et al.   CIRCULATION

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE

(2016) Emil M. deGoma et al.   Circulation-Cardiovascular Genetics

Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature

(2016) Bruce Wong et al.   CLINICAL THERAPEUTICS

Identifying familial hypercholesterolemia in acute coronary syndrome

(2016) Baris Gencer et al.   CURRENT OPINION IN LIPIDOLOGY

A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries

(2016) Liv Mundal et al.   CURRENT OPINION IN LIPIDOLOGY

Diagnostic scoring for familial hypercholesterolaemia in practice

(2016) Kate Haralambos et al.   CURRENT OPINION IN LIPIDOLOGY

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

(2016) Marianne Benn et al.   EUROPEAN HEART JOURNAL

Cardiovascular risk stratification in familial hypercholesterolaemia

(2016) Mahtab Sharifi et al.   HEART

Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

(2016) Paulo A. Lotufo et al.   Journal of Clinical Lipidology

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

(2016) Amit V. Khera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Progress in the care of familial hypercholesterolaemia: 2016

(2016) Damon A Bell et al.   MEDICAL JOURNAL OF AUSTRALIA

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United StatesCLINICAL PERSPECTIVE

(2016) Emil M. deGoma et al.   Circulation-Cardiovascular Genetics

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

(2016) Raul D Santos et al.   Lancet Diabetes & Endocrinology

Ecuador's National Health and Nutrition Survey: objectives, design, and methods

(2015) Wilma B. Freire et al.   ANNALS OF EPIDEMIOLOGY

Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects

(2015) Cinthia E. Jannes et al.   ATHEROSCLEROSIS

Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)

(2015) Stephen F. Weng et al.   ATHEROSCLEROSIS

Familial hypercholesterolaemia: A global call to arms

(2015) Antonio J. Vallejo-Vaz et al.   ATHEROSCLEROSIS

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales

(2015) K. Haralambos et al.   ATHEROSCLEROSIS

Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted

(2015) Núria Homedes et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

The Agenda for Familial Hypercholesterolemia

(2015) Samuel S. Gidding et al.   CIRCULATION

Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening

(2015) Siddharth Singh et al.   Current Atherosclerosis Reports

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia

(2015) Matthew K. Ito et al.   DRUGS

Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death

(2015) Henriette Walaas Krogh et al.   EUROPEAN HEART JOURNAL

Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement

(2015) Ana Margarida Medeiros et al.   GENETICS IN MEDICINE

Cascade Screening in Familial Hypercholesterolemia: Advancing Forward

(2015) Raul D. Santos et al.   Journal of Atherosclerosis and Thrombosis

La Encuesta Nacional de Salud de Chile entrega información valiosa para la planificación de políticas de salud: Análisis de la Nefropatía Diabética como indicador de ahorro potencial

(2015) Sebastián Cabrera et al.   REVISTA MEDICA DE CHILE

Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers

(2014) Joost Besseling et al.   ATHEROSCLEROSIS

Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: Insights from a patient survey

(2014) Eric Bruckert et al.   ATHEROSCLEROSIS SUPPLEMENTS

What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?

(2014) Raul D. Santos   ATHEROSCLEROSIS SUPPLEMENTS

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia

(2014) Jacques Genest et al.   CANADIAN JOURNAL OF CARDIOLOGY

Homozygous familial hypercholesterolemia: The c.1055G>A mutation in the LDLR gene and clinical heterogeneity

(2014) María Teresa Magaña Torres et al.   Journal of Clinical Lipidology

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

(2014) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010

(2014) Liv Mundal et al.   Journal of the American Heart Association

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry

(2013) Emily C. O’Brien et al.   AMERICAN HEART JOURNAL

I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)

(2013) RD Santos et al.   Arquivos Brasileiros de Cardiologia

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

(2013) Gerald F. Watts et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum

(2013) Andrzej Rynkiewicz et al.   Journal of Clinical Lipidology

Extensive Xanthomas and Severe Subclinical Atherosclerosis in Homozygous Familial Hypercholesterolemia

(2013) Viviane Z. Rocha et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Severe familial hypercholesterolaemia: Current and future management

(2012) Michel Farnier et al.   Archives of Cardiovascular Diseases

Statin treatment of children with familial hypercholesterolemia – Trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus?

(2012) Alpo Vuorio et al.   ATHEROSCLEROSIS

Low Prevalence of Mutations in Known Loci for Autosomal Dominant Hypercholesterolemia in a Multiethnic Patient Cohort

(2012) Zahid Ahmad et al.   Circulation-Cardiovascular Genetics

Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe

(2012) N. Mata et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Uso de ezetimibe en el tratamiento de la hipercolesterolemia

(2011) M.B. Araujo et al.   ANALES DE PEDIATRIA

Hipercolesterolemias graves en pediatría. Presentación de dos casos

(2011) Maria Araujo   Archivos Argentinos de Pediatria

Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortality

(2011) Jorie Versmissen et al.   ATHEROSCLEROSIS

Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia

(2011) Gerardo Vaca et al.   ATHEROSCLEROSIS

Molecular characterization of familial hypercholesterolemia in Spain

(2011) Lourdes Palacios et al.   ATHEROSCLEROSIS

Familial hypercholesterolaemia: A model of care for Australasia

(2011) Gerald F. Watts et al.   ATHEROSCLEROSIS SUPPLEMENTS

Extreme xanthomatosis in patients with both familial hypercholesterolemia and cerebrotendinous xanthomatosis

(2011) R Huijgen et al.   CLINICAL GENETICS

Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies

(2011) L. Nherera et al.   HEART

Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia

(2011) Mariko Harada-Shiba et al.   Journal of Atherosclerosis and Thrombosis

National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants

(2011) Farshad Farzadfar et al.   LANCET

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)

(2011) Nelva Mata et al.   Lipids in Health and Disease

Visual Vignette

(2010) Alvaro Burgos et al.   Endocrine Practice

Defining the challenges of FH Screening for familial hypercholesterolemia

(2010) Joep C. Defesche   Journal of Clinical Lipidology

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands

(2009) A.H. Pijlman et al.   ATHEROSCLEROSIS

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors

(2008) R. Alonso et al.   ATHEROSCLEROSIS

Recommendations for the use of LDL apheresis

(2008) G.R. Thompson   ATHEROSCLEROSIS

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

(2008) A. Neil et al.   EUROPEAN HEART JOURNAL